Pioglitazone HCL and Metformin HCL · METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg/1 · Tablet · Oral · Torrent Pharmaceuticals Limited
NDC 13668-0281-33 · 180 TABLET in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 51% in a year, to $0.2861 per unit — and generics that get this cheap tend to get abandoned rather than defended.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Pioglitazone HCL and Metformin HCL — NDC 13668-0281-33," retrieved September 3, 2026, https://drugdashboards.com/drug/13668028133.
Free to cite with attribution — see how the data is put together.